Symbols

DRIO

DarioHealth·NASDAQ

--(--)

DRIO fundamentals

DRIO Q4 2025 Earnings

DarioHealth (DRIO) released its earnings on Mar 19, 2026: revenue was 5.20M (YoY -31.58%), beat estimates; EPS was -0.76 (YoY +52.50%), beat estimates.

Revenue / YoY

5.20M

-31.58%

EPS / YoY

-0.76

+52.50%

Report date

Mar 19, 2026

DRIO Earnings Call Summary for Q4,2025

Record Contract Growth: 85 new deals in 2025 (vs. 40 target), with 2-10x larger contract sizes.
AI-Driven Advantage: 13B+ clinical data points power DarioIQ, enabling 80%+ member engagement per account.
Financial Turnaround: Operating expenses down 31% in 2025, targeting 30% loss narrowing in 2026 and breakeven by mid-2027.
Pipeline Explosion: $122M pipeline (up from $69M) driven by 2027 opportunities, with 2026 revenue growth accelerating in H2.
Strategic Expansion: Launching largest fully insured client in Q1 2027, with HCSC deployment to 25M members.

Earnings

EPS

Revenue

Revenue & Expenses

DRIO has released its 2025 Q4 earnings report, with revenue of 5.23M, reflecting a YoY change of -31.21%, and net profit of -9.03M, showing a YoY change of 6.24%. The Sankey diagram below clearly presents DRIO's revenue sources and cost distribution.

Key Indicators

DarioHealth (DRIO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

DarioHealth (DRIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

DarioHealth (DRIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

DarioHealth (DRIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown